Institutional investors purchased a net $522.4 thousand shares of CVM during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 6.73% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 666.8 Thousand shares of CEL-SCI Corp
RAYMOND JAMES & ASSOCIATES, INC.... Bought 114.4 Thousand shares of CEL-SCI Corp
RAMIUS ADVISORS LLC Bought 49.0 Thousand shares of CEL-SCI Corp